Skip to content

Difference between effect of Intraoperative goal-directed fluid therapy versus conventional fluid therapy in major gastrointestinal cancer surgery and postoperative pulmonary complication; a prospective randomized controlled trial

Intraoperative goal-directed fluid therapy versus conventional fluid therapy in major gastrointestinal cancer surgery on postoperative pulmonary complication; a prospective randomized controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056510
Enrollment
104
Registered
2023-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C15-C26- Malignant neoplasms of digestive organs Health Condition 2: C15-C26- Malignant neoplasms of digestive organs Health Condition 3: O- Medical and Surgical Health Condition 4: O- Medical and Surgical Health Condition 5: O- Medical and Surgical

Interventions

Intervention1: Goal directed fluid therapy: Guided fluid therapy during surgery, according to Stroke volume variation by flow track intraoperatively Control Intervention1: Conventional fluid therapy d

Sponsors

Bhagwan mahaveer cancer hospital jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (18 years or older) posted for Elective Open or Laparoscopic ASA grade 1-2 patients Patients posted for gastro-intestinal cancer surgeries

Exclusion criteria

Exclusion criteria: Patients posted for liver resection and esophageal surgery Expected massive blood loss >500ml

Design outcomes

Primary

MeasureTime frame
Post operative Pulmonary complicationTimepoint: Post operative Pulmonary complication during intraoperative, post operative at 24hr, 48hrs and within 30 days post operatively

Secondary

MeasureTime frame
To assess 30 days perioperative morbidity & mortality along with length of hospital stay Timepoint: 0, 24 hr, 48hr

Countries

India

Contacts

Public ContactRavi Shankar Sharma

Bhagwan mahaveer cancer hospital and research center jaipur

rvaiims1981@gmail.com07742153220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026